Skip to main content

Bioceres Crop Solutions Corp. (BIOX) Stock Forecast

Data as of May 2, 2026

Basic Materials · Current price $0.47 (+0.83%)

Consensus Target
$2.00
Upside
+324.6%
Analysts
2
Rating
Hold(3.00)

Price Target Range

Low $2.00High $2.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Jan 2, 2026Austin MoellerCanaccord Genuity$2.00+324.6%
Sep 10, 2025Ben KlieveLake Street$5.00+961.6%
Oct 21, 2024Kristen OwenOppenheimer$13.00+2660.1%
Sep 11, 2024Ben KlieveLoop Capital Markets$13.00+2660.1%
Sep 11, 2024Austin MoellerCanaccord Genuity$12.50+2553.9%
Sep 10, 2024Kristen OwenOppenheimer$16.00+3297.0%
Jul 2, 2024Scott FortuneRoth Capital$15.00+3084.7%

BIOX vs Sector & Market

MetricBIOXBasic Materials AvgLarge Cap Avg
Analyst Rating3.002.362.41
Analyst Count2718
Target Upside+324.6%+52.4%+14.9%
P/E Ratio-0.13-16.6031.19

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$307M$307M$307M1
2027-06-30$379M$379M$379M1
2028-06-30$511M$511M$511M1
2029-06-30$579M$579M$579M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$-0.16$-0.16$-0.161
2027-06-30$0.05$0.05$0.051
2028-06-30$0.56$0.56$0.561
2029-06-30$0.82$0.82$0.821

Frequently Asked Questions

What is the analyst consensus for BIOX?

The consensus among 2 analysts covering Bioceres Crop Solutions Corp. (BIOX) is Hold with an average price target of $2.00.

What is the highest price target for BIOX?

The highest price target for BIOX is $16.00, set by Kristen Owen at Oppenheimer on 2024-09-10.

What is the lowest price target for BIOX?

The lowest price target for BIOX is $2.00, set by Austin Moeller at Canaccord Genuity on 2026-01-02.

How many analysts cover BIOX?

2 analysts have issued ratings for Bioceres Crop Solutions Corp. in the past 12 months.

Is BIOX a buy or sell right now?

Based on 2 analyst ratings, BIOX has a consensus rating of Hold (3.00/5) with a +324.6% upside to the consensus target of $2.00.

What are the earnings estimates for BIOX?

Analysts estimate BIOX will report EPS of $-0.16 for the period ending 2026-06-30, with revenue estimated at $307M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.